FDAnews Announces — How to Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors by 50% or More Workshop, Sept. 19-20, Raleigh, NC
Falls Church, VA (PRWEB) July 21, 2016 -- How to Reduce Human Error on the Drug and Device Manufacturing Floor:
Reduce Errors by 50% or More
**Presented by FDAnews and Ginette M. Collazo, Inc.**
Sept. 19-20, 2016 · Raleigh, NC
http://www.fdanews.com/humanerrordrugdevice2
Dr. Ginette Collazo, a 15 year veteran of helping drug, biologic and device firms reduce manufacturing errors by 50 percent or more, will conduct a one-of-a-kind workshop that teaches quality managers and manufacturing excellence professionals how to reduce errors and improve quality metrics.
Based on her ground-breaking research, Dr. Collazo explains how small improvements in both manufacturing systems and improved employee training can deliver big results.
Dr. Collazo recently worked with a drug manufacturer that had a baseline rate of 4.7 errors per thousand units manufactured. But with effective human error reduction strategies, the error rate was reduced to 1.9.
A 60% reduction achieved in just 10 months.
In addition to Dr. Collazo’s analysis of how and why errors occur, this workshop features multiple interactive exercises allowing attendees to work in small groups with colleagues to tackle common manufacturing problems.
Dr. Collazo will work with the small groups and help them form solutions they can take back to their facilities.
Some of the interactive exercises include:
• What’s not working in facilities: Participants will be broken into groups and asked to describe the most common human errors within their facilities. The workshop will then reconvene and break-out group leaders will describe what they uncovered. A list of the most common problems will be tallied to help focus the discussion.
• CAPA: Determining when human error reduction is the key to a successful solution and FDA compliance. Broken into small groups, each group will be asked to determine if a CAPA solution is effective and if human error prevention related provisions will satisfy the FDA.
• Practice identifying which human error techniques are best applied to certain situations. For example, when is a human error really a human resources problem? This interactive exercise will help attendees know what to apply and when.
• Brainstorming root causes for real cases. Using the situations identified in the first interactive exercise the group will apply applicable tools. Getting to the true root cause of an error is commonly described as the hardest part of reducing errors.
Who Will Benefit:
• QA/QC directors and managers
• Process improvement/excellence professionals
• Training directors and managers
• Manufacturing operations directors
• Human factors professionals
• Plant engineering
• Compliance officers
• Regulatory professionals
• Executive management
Meet the Instructor:
Ginette Collazo, Ph.D., has spent more than 15 years in technical training, organizational development and human reliability. She has worked with Bristol-Myers Squibb, Johnson & Johnson, Schering-Plough, Wyeth and Medtronic, many more small and mid-sized drug and device companies. An active researcher in specialized studies related to human reliability, she is the author of numerous publications on these topics.
Workshop Details:
How to Reduce Human Error on the Drug and Device Manufacturing Floor:
Reduce Errors by 50% or More
**Presented by FDAnews and Ginette M. Collazo, Inc.**
Sept. 19-20, 2016 · Raleigh, NC
http://www.fdanews.com/humanerrordrugdevice2
Tuition:
$1,797
Easy Ways to Register:
Online: http://www.fdanews.com/humanerrordrugdevice2
By phone: 888-838-5578 or 703-538-7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Michelle Butler, FDANEWS, http://www.fdanews.com, +1 (703) 538-7665, [email protected]
Share this article